In a model of amyotrophic lateral sclerosis (ALS), IGF-1 treatment, acting specifically through astrocytes, reduced neurotoxicity and rescued the disease-associated neurite retraction (Dodge et al., 2008). The gene discussed is IGF1; the disease is amyotrophic lateral sclerosis.